ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

<p>In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.</p>